ROIV

ROIVANT SCIENCES LTD

ROIV·G76279101·US·Common Stock·Healthcare - Biotechnology-13D/G

ROIV (ROIVANT SCIENCES LTD) is held by 190 institutional investors as of Q1 2026. Largest holders: FMR LLC ($2.2B), MORGAN STANLEY ($1.4B), BlackRock, Inc. ($1.2B). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 128 funds bought ROIV.

190
Holders
(17 Elite)
$12.1B
Total Value
64% (201)
Consensus
128 buying - 73 selling
13F: Insider & Congress:
ROIVSmart Money Verdict
View all
Held by 190 funds
17 elite
Who's Trading
InsiderVEVenker EricSell $5.1MJun 24, 2026
InsiderVEVenker EricSell $1.5MJun 24, 2026
ActivistMorgan StanleyMorgan Stanley6.9%May 12, 2026
ActivistRVRamaswamy Vivek3.6%May 6, 2026
InsiderVEVenker EricSell $5.9MApr 20, 2026
InsiderGMGline MatthewSell $8.4MApr 16, 2026
CongressLisa McClainLisa McClainSale $1,001 - $15,000Oct 31, 2025
CongressLisa McClainLisa McClainSale $1,001 - $15,000Oct 30, 2025
CongressLisa McClainLisa McClainBuy $1,001 - $15,000Oct 30, 2025
CongressLisa McClainLisa McClainBuy $1,001 - $15,000Jun 17, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
78M(+18.6%)$2.2B0.1%+141.92%
45
Decreased
51.8M(-11.2%)$1.4B0.1%+167.92%
0
Increased
44.3M(+7.5%)$1.2B0.0%+178.68%
34
Increased
22.6M(+23.0%)$626.6M0.1%+67.17%
38
New
20.7M$572.9M0.0%+29.16%
44
New
19.8M$549.5M0.0%+29.16%
43
Decreased
16.2M(-6.8%)$448.4M0.0%+223.64%
0
Increased
12.8M(+19.8%)$354.4M0.5%+101.67%
52
Increased
11.1M(+1.2%)$307.8M0.0%+84.38%
31
Increased
10.2M(+24.9%)$282.1M0.0%+150.92%
38
Increased
9.7M(+260x)$268M1.5%+29.46%
78
Decreased
7.5M(-19.2%)$207M0.0%+207.99%
0
Increased
7.1M(+2.0%)$196M0.3%+28.58%
37
Increased
7M(+31.1%)$193.7M0.0%+83.50%
39
Increased
6.7M(+3.3%)$184.3M0.5%+221.69%
44
Increased
6.4M(+182.2%)$178.4M0.0%+58.29%
49
Increased
6.3M(+208.7%)$174.5M0.2%+39.23%
59
Increased
5.9M(+575.2%)$161.6M0.1%+33.96%
49
Decreased
4.9M(-12.4%)$134.8M0.8%+164.07%
0
Increased
3.5M(+7.1%)$97.5M0.0%+204.43%
32

Showing 1-20 of 209

1 / 11

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used